Comparison of breast carcinoma prognostic/predictive biomarkers on cell blocks obtained by various methods: Cellient, formalin and thrombin

Acta Cytologica

Volumn 56, Issue 3, 2012, Pages 289-296

  Gorman, Blythe K ^a   Kosarac, Ognjen ^a   Chakraborty, Subhendu ^a   Schwartz, Mary R ^a   Mody, Dina R ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Biomarkers; Breast carcinoma; Cell block; Cellient; Cytology; Fine needle aspiration; Immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FORMALDEHYDE; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; THROMBIN;

ADULT; AGED; ASPIRATION BIOPSY; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SURGERY; CELLIENT CELL BLOCK; CLINICAL ARTICLE; CYTOLOGY; FALSE NEGATIVE RESULT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FORMALDEHYDE CELL BLOCK; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; REVIEW; THROMBIN CELL BLOCK;

EID: 84860757155     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000337436     Document Type: Review

References (26)

1. Hammond ME, Hays DF, Dowsett M, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 2010; 134:e48-e72.
2. Wolff AC, Hammond EM, Schwartz JN, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 118-145. (Pubitemid 350003059)
3. Phillips T, et al: Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy. Appl Immunohistochem Mol Morphol 2007; 15: 325-331. (Pubitemid 47329926)
4. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 15 5- 168.
5. Veronese SM, Maisano C, Scibilia J: Comparative prognostic value of Ki-67 and MIB- 1 proliferation indices in breast cancer. Anticancer Res 1996; 16: 2717-2722.
6. Sauer T, Ebeltoft K, Pedersen MK, Karesen R: Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors. Cytojournal 2010; 7: 24.
7. Troncone G, Panico L, Vetrani A, et al: cerbB- 2 expression in FNAB smears and matched surgical specimens of breast cancer. Diagn Cytopathol 1996; 14: 135-139. (Pubitemid 26104488)
8. Railo M, Nordling S, Krogerus L, Sioris T, von Smitten K: Preoperative assessment of proliferative activity and hormone receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen. Diagn Cytopathol 1996; 15: 205-210. (Pubitemid 26404635)
9. Konofaos P, Kontzoglou K, Georgoulakis J, et al: The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors. Surg Oncol 2006; 15: 257-266. (Pubitemid 46771199)
10. Tafjord S, Bohler PJ, Risberg B, Torlakovic E: Estrogen and progesterone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol 2002; 26: 137-141. (Pubitemid 34195273)
11. Cano G, Milanezi F, Leitao D, et al: Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol 2003; 29: 207-211. (Pubitemid 37193648)
12. Lofgren L, Skoog L, von Schoultz E: Hormone receptor status in breast cancer-comparison between surgical specimens and fine needle aspiration biopsies. Cytopathology 2003; 14: 136-142. (Pubitemid 36819181)
13. Gong Y, WF Symmans, Krishnamurthy S, Patel S, Sneige N: Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma. Cancer 2004; 102: 34-40. (Pubitemid 38209571)
14. Goldstein NS, Ferkowicz M, Odish E, Mani A, Hastah F: Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol 2003; 120: 86-92. (Pubitemid 37046374)
15. Goldstein NS, Hunter S, Forbes S, Odish E, Tehrani M: Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity. Appl Immunohistochem Mol Morphol 2007; 15: 203-207. (Pubitemid 46828230)
16. Qiu J, Kulkarni S, Chandrasekhar R, et al: Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones. Am J Clin Pathol 2010; 134: 813-819.
17. Khoury T, Sait S, Hwang H, et al: Delay to formalin fixation effect on breast biomarkers. Mod Pathol 2009; 22: 1457-1467.
18. Oyama T, Ishikawa Y, Hayashi M, Arihiro K, Horiguchi J: The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer. Breast Cancer 2007; 14: 182-188.
19. Allred DC: Issues and updates: evaluating estrogen receptor- , progesterone receptor, and HER2 in breast cancer. Mod Pathol 2010; 23:S52-S59.
20. Gown AM: Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol2008; 21:S8-S15. (Pubitemid 351592775)
21. Hanley KZ, Birdsong GG, Cohen C, Siddiqui MT: Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations. Cancer 2009; 117: 279-288.
22. Williams SL, Birdsong GG, Cohen C, Siddiqui MT: Immunohistochemical detection of estrogen and progesterone receptor and Her2 expression in breast carcinomas: comparison of cell block and tissue block preparations. Int J Clin Exp Pathol 2009; 2: 476-480.
23. Shabaik A, Lin G, Peterson M, et al: Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma. Diagn Cytopathol 2011; 39: 328-332.
24. Wagner DG, Russell DK, Benson JM, et al: Cellient TM automated cell block versus traditional cell block preparation: a comparison of morphological features and immunohistochemical staining. Diagn Cytopathol 2011; 10: 730-736.
25. Akalin A, Lu D, Woda B, Moss L, Fischer A: Rapid cell blocks improve accuracy of breast FNAs beyond that provided by conventional cell blocks regardless of immediate adequacy evaluation. Diagn Cytopathol 2008; 36: 523-529. (Pubitemid 351897384)
26. Beatty B, Bryant R, Wang W, et al: HER-2/ neu detection in fine needle aspirates of breast cancer. Am J Clin Pathol 2004; 122: 246-255.